Want to buy for someone else? You can purchase a token at check out.
This course is free with a membership upgrade!
Upgrade to a Standard membership and gain access to 1,000+ CE and professional development courses.
Overview
The goal of this course is to provide an overview of pharmacological options for healthcare team members that may treat HIV in adolescents and adults.Goals and Learning Outcomes
Human immunodeficiency virus (HIV) weakens a person’s immune system, making it difficult for the person to fight disease and infection. Once HIV has been diagnosed, treatment depends on the extent of disease and the presence of any opportunistic infections (OIs), with the goal being to stabilize the immune system so OIs are less likely to occur. HIV cannot be cured, but it can be controlled (Centers for Disease Control and Prevention [CDC], 2022a; Department of Health and Human Services [DHHS], 2022).
The goal of this course is to provide an overview of pharmacological options for those members of the healthcare team that may treat human immunodeficiency virus (HIV) in adolescents and adults.
All drug-related information cited in this course was obtained from the manufacturer package inserts accessed March 12, 2023, and the National Institutes of Health HIV Drug Database, unless otherwise noted.
- Identify the nine classes of HIV medication, pharmacokinetic enhancers, and the standard regimens currently used for the treatment of HIV in various populations.
- Recall the criteria, adverse effects, and monitoring requirements for antiretroviral therapy.
- Recognize drugs used for pre and post-exposure prophylaxis and opportunistic infections.
Course Details
Course Originally Released on : 8/1/2023
Course Expiration Date : 12/31/2026
REL-ACU-0-PHIV
Accreditations
NURSES
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Provider approved by the California Board of Registered Nursing, CEP#13791
Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, Kansas State Board of Nursing, Kentucky Board of Nursing, Michigan Board of Nursing, Mississippi Board of Nursing, New Hampshire Board of Nursing, New Mexico Board Of Nursing, North Dakota Board of Nursing, South Carolina Board Of Nursing and West Virginia Board Of Registered Nurses
Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.
Disclosures
None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.